Artificial Cornea and Corneal Implant Market Size, Share & Trends Analysis Report By Type (Human Cornea, Artificial Cornea), By Transplant Type (Penetrating Keratoplasty, Endothelial Keratoplasty, Anterior lamellar Keratoplasty, Keratoprosthesis), By Disease Indication (Fuchs' Dystrophy, Fungal Keratitis, Keratoconus, Others), By End-User (Hospitals & Ambulatory Surgical Center, Specialty Clinics) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Artificial Cornea and Corneal Implant Market Size Analysis

The global artificial cornea and corneal implant market size was valued at USD 525.73 million in 2025 and is projected to grow from USD 568.31 million in 2026 to USD 1059.73 million by 2034, registering a CAGR of 8.1% during the forecast period from 2026 to 2034. North America dominated the artificial cornea and corneal implant market with a market share of 38.6% in 2025.

A cloudy cornea is surgically removed and replaced with a clear donor cornea in a corneal transplant. Donated tissue comes from people who have generously given their eyes or organs to science for the benefit of others. Eye banks ensure that the donor corneas that are used in transplants remain in a fresh state at all times.

Future growth of the global artificial cornea and corneal implant market is anticipated to be driven by the increasing geriatric population and the prevalence of eye diseases. It is reported that approximately 10 million people worldwide have corneal blindness. The likelihood of nerve regeneration following cornea transplantation with a human donor cornea is low, whereas the likelihood of nerve regeneration following implantation of a biosynthetic cornea is high.

Artificial Cornea and Corneal Implant Market Segmental Analysis

By Type

The human cornea segment dominated the artificial cornea and corneal implant market with a market share of 82.7% in 2025, supported by its established use in corneal transplantation and broad clinical acceptance across multiple corneal disorders. Favorable tissue integration and long-standing surgical familiarity continue to reinforce its leading position.

The artificial cornea segment is expected to grow at the fastest CAGR of 10.86% during the forecast period 2026–2034, driven by its use in patients who are unsuitable for donor transplantation or face repeated graft failure. Advances in biomaterials and implant design are also expanding its role in complex corneal reconstruction.

Request Customizationto receive a tailored report.

By Transplant Type

The penetrating keratoplasty segment dominated the artificial cornea and corneal implant market with a market share of 36.4% in 2025, supported by its use in full-thickness corneal replacement for advanced scarring, structural damage, and severe corneal disease. Its ability to address multiple affected corneal layers keeps it relevant in complex transplant cases.

The keratoprosthesis segment is expected to register the fastest CAGR of 10.18% during the forecast period 2026–2034, supported by its role in severe cases where conventional donor grafts have failed or are unlikely to succeed. Endothelial keratoplasty is widely used for disorders affecting the inner corneal layer, while anterior lamellar keratoplasty supports selective replacement of diseased anterior tissue while preserving healthy endothelium.

By Disease Indication

The Fuchs' dystrophy segment dominated the artificial cornea and corneal implant market with a market share of 32.5% in 2025 and is also expected to register the fastest CAGR of 8.69% during the forecast period 2026–2034. Its strong position is linked to progressive endothelial cell loss that can lead to corneal swelling and visual impairment, often requiring endothelial or full-thickness transplantation in advanced cases.

Fungal keratitis remains an important indication where severe infection can cause irreversible corneal damage and require surgical replacement. Keratoconus contributes to transplant procedures in advanced cases with substantial thinning or scarring, while the others segment includes additional corneal diseases and injuries requiring implant-based treatment.

By End-User

The hospitals & ambulatory surgical center segment dominated the artificial cornea and corneal implant market with a market share of 76.8% in 2025, supported by access to ophthalmic operating rooms, donor-tissue handling capabilities, and specialized surgical teams for complex corneal procedures. Their ability to manage perioperative care and postoperative complications further strengthens their role in transplantation.

The specialty clinics segment is expected to grow at the fastest CAGR of 8.51% during the forecast period 2026–2034, driven by the expansion of dedicated corneal and ophthalmic centers offering focused diagnostics, follow-up care, and selected surgical procedures in specialized settings.

Speak to an Analystto discuss market opportunities.

Artificial Cornea and Corneal Implant Market Regional Outlook

North America Artificial Cornea and Corneal Implant Market Analysis

The North America artificial cornea and corneal implant market accounted for the largest regional share of 38.6% in 2025, supported by advanced ophthalmic surgery, established eye-bank networks, and access to complex corneal procedures. The U.S. artificial cornea and corneal implant market benefits from high transplant activity, with 52,396 domestic keratoplasty procedures performed in 2025, while DMEK represented the most common procedure, highlighting substantial clinical capacity for corneal replacement technologies.

The Canada artificial cornea and corneal implant market is supported by specialized ophthalmology centers and established transplant programs, creating a clinical base for artificial implants in patients who are unsuitable for conventional donor transplantation or face repeated graft failure.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific Artificial Cornea and Corneal Implant Market Analysis

The Asia Pacific artificial cornea and corneal implant market is expected to register the fastest CAGR of 9.42% during the forecast period, supported by unmet corneal-treatment needs, expansion of specialty eye hospitals, and broader access to advanced ophthalmic surgery. The Japan artificial cornea and corneal implant market has around 19,000 people with visual impairment related to corneal disease and approximately 2,000 patients currently awaiting transplantation, while 54 eye banks operate nationwide, highlighting continued need for additional corneal replacement options.

The China artificial cornea and corneal implant market is supported by expansion of specialty ophthalmology services and development of biomaterial-based alternatives where donor tissue availability remains constrained. The South Korea market benefits from advanced biomedical manufacturing and tertiary eye-care capabilities.

Europe Artificial Cornea and Corneal Implant Market Analysis

The Europe artificial cornea and corneal implant market is expected to grow at a CAGR of 7.12% during the forecast period, supported by specialized corneal surgery, tissue-bank infrastructure, and development of alternatives for patients with limited donor-graft options. The U.K. artificial cornea and corneal implant market faces persistent donor-tissue pressure, with NHS eye banks operating around 20% below the inventory required to supply hospitals, creating a clinical rationale for technologies that reduce reliance on donor corneas.

The Germany artificial cornea and corneal implant market benefits from established university ophthalmology centers and expertise in complex corneal reconstruction, supporting adoption of advanced implant technologies for difficult-to-treat cases. 

Artificial Cornea and Corneal Implant Market Competitive Landscape

artificial cornea and corneal implant market is moderately fragmented, with ophthalmic device manufacturers, keratoprosthesis developers, biomaterials specialists, and regional implant suppliers competing across donor-alternative and corneal reconstruction applications. Leading players include CorNeat Vision, EyeYon Medical, KeraMed, AJL Ophthalmic, and Addition Technology, which together are estimated to account for approximately 30–35% of the global market share in the artificial cornea and corneal implant market.

Established players compete through clinical evidence, implant biocompatibility, surgeon training, and regulatory approvals. Emerging and regional players within the Artificial Cornea and Corneal Implant Market ecosystem compete through specialized implant designs, cost-focused product development, local clinical partnerships, and targeted solutions for complex corneal cases.

List of Key and Emerging Players in Artificial Cornea and Corneal Implant Market